ENGLEWOOD, Colo., Oct. 23, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that it has hired Neil Friery as the President and Chief Operating Officer (COO) of its Monitoring Solutions Division. As […]
Other News
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants
MONTREAL and CHARLOTTE, N.C., Oct. 23, 2020 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced the pricing of its previously announced underwritten public offering of 3,810,097 of its common shares, and to certain investors in lieu […]
New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status
– Jardiance (empagliflozin) reduced risk for the composite endpoint of cardiovascular death and hospitalization for heart failure, as well as serious adverse kidney outcomes, in adults with or without chronic kidney disease at baseline. The trial included people with and without diabetes – Sub-analysis findings from the EMPEROR-Reduced phase III […]
BD Announces Executive Leadership Appointments
Patrick Kaltenbach appointed chief technology officer Dave Hickey promoted to president, Life Sciences segment FRANKLIN LAKES, N.J., Oct. 22, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Patrick Kaltenbach as executive vice president and chief technology officer, and the promotion of Dave Hickey to executive vice […]
Sequana Medical Announces Strong Interim Results From RED DESERT alfapump® DSR Study and Provides Business Update
RED DESERT: Results from first five patients indicaterepeated dose alfapump DSR therapy to be safeandeffective Interim data support DSR hypothesis: kidneys eliminate free water to maintain patients’ serum sodium levels No patients required loop diuretic therapy during the six-week alfapump DSR treatment period Followingalfapump DSR treatment, loop diuretic responsiveness was restored to near normal levels; effect was durable for months post-treatmentwith majority of patients requiring little or no diuretic therapy Full RED DESERT data on track […]
Edwards Lifesciences Reports Third Quarter Results
IRVINE, Calif., Oct. 21, 2020 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended September 30, 2020. Third Quarter Highlights and Outlook Sales of $1.1 billion grew 4%; similar underlying1 growth expected in the fourth quarter TAVR global sales grew 6% EPS was $0.52; adjusted1 EPS grew 9% to $0.51 TMTT clinical trials now enrolling […]
UNC Researchers Identify Genetic Variant Linked to Drug-Induced Hypertension with Avastin®
Results from largest genomic analysis offer pathway to preventive patient screening CHAPEL HILL, N.C., Oct. 22, 2020 /PRNewswire/ — In the largest study of its kind, researchers from the University of North Carolina at Chapel Hill (UNC) have discovered a genetic variant that can be used to predict if patients will develop hypertension from […]
IRRAS Announces Key IRRAflow Commercial Milestones in Germany
STOCKHOLM, Oct. 22, 2020 /PRNewswire/ — IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced important commercial milestones from the launch of its IRRAflow system in Germany. The company generated its initial revenue in Germany and also completed the first German patient since launching the most recent […]
FibroGen Presents Late-Breaker Abstract Results on Associations between Hemoglobin Levels and Cardiovascular Outcomes in Roxadustat-Treated Patients with Anemia of Chronic Kidney Disease (CKD)
In non-dialysis and dialysis-dependent CKD patients, Major Adverse Cardiovascular Event (MACE) and MACE+ incidence rates were lowest when patients achieved hemoglobin levels ≥ 10 g/dL Two analyses of pooled data from the roxadustat global Phase 3 development program to be presented during the American Society of Nephrology Kidney Week 2020 Reimagined SAN FRANCISCO, Oct. 22, 2020 […]
St. Luke’s University Health Network Selects GE Healthcare for $11 Million Ultrasound Purchase to Create System-wide Efficiencies
GE Healthcare will install 76 ultrasound systems in 2020 to deploy a fleet of AI-powered technology, making this GE Healthcare’s largest ever single-order ultrasound deal in the U.S. Equipment will enhance standardizing care in radiology, vascular and echocardiography GE Healthcare’s Viewpoint 6 automated reporting and post-processing system expected to save […]



